Glutathione S-transferases and aromatic DNA adducts in smokers' bronchoalveolar macrophages

Lung Cancer

Volumn 39, Issue 3, 2003, Pages 265-272

  Piipari, Ritva ^a   Nurminen, Tuula ^a   Savela, Kirsti ^a   Hirvonen, Ari ^a   Mäntylä, Timo ^b   Anttila, Sisko ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Aromatic DNA adducts; Bronchoalveolar macrophages; Carcinogenesis; CYP; Glutathione S transferases; Lung cancer; Smoking

Indexed keywords

CYTOCHROME P450 3A; DNA; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M3; PROTEIN; PROTEIN GSTA; PROTEIN GSTP; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA ADDUCT; FEMALE; GENOTYPE; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; CYTOCHROME P-450 ENZYME SYSTEM; DNA ADDUCTS; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SMOKING;

EID: 0347927399     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00510-X     Document Type: Article

References (28)

1. Ketterer B., Harris J.M., Talaska G., et al. The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ. Health Perspect. 98:1992;87-94.
2. Comstock K.E., Widersten M., Hao X., Henner W.D., Mannervik B. A comparison of the enzymatic and physicochemical properties of human glutathione transferase M4-4 and three other human mu class enzymes. Arch. Biochem. Biophys. 311:1994;487-495.
3. Seidegård J., Vorachek W.R., Pero R.W., Pearson W.R. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. 85:1988;7293-7297.
4. Inskip A., Elexperu-Camiruaga J., Buxton N., et al. Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A. Biochem. J. 312:1995;713-716.
5. Ali-Osman F., Akande O., Antoun G., Mao J.-X., Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. J. Biol. Chem. 272:1997;10004-10012.
6. Hu X., O'Donnell R., Srivastava S.K., et al. Active site architecture of polymorphic forms of human glutathione S-transferase P1-1 accounts for their enantioselectivity and disparate activity in the glutathione conjugation of 7β,8α-dihydroxy-9α,10α-oxy-7,8,9,10-tetrahydrobenzo (a)pyrene. Biochem. Biophys. Res. Comm. 235:1997;424-428.
7. Hu X., Xia H., Srivastava S.K., et al. Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem. Biophys. Res. Commun. 238:1997;397-402.
8. Sundberg K., Johansson A.-S., Stenberg G., et al. Differences in the catalytic efficiencies of allelic variants of glutathione S-transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis (Lond.). 19:1998;433-436.
9. Coles B.F., Morel F., Rauch C., et al. Effect of polymorphism in the human glutathione S-transferase A1 promoter on hepatic GSTA1 and GSTA2 expression. Pharmacogenetics. 11:2001;663-669.
10. Anttila S., Hirvonen A., Vainio H., Husgafvel-Pursiainen K., Hayes J.D., Ketterer B. Immunohistochemical localization of glutathione S-transferases in human lung. Cancer Res. 53:1993;5643-5648.
11. Juronen E., Tasa G., Uuskula M., Pooga M., Mikelsaar A.-V. Purification, charachterization and tissue distribution of human class theta glutathione S-transferase T1-1. Biochem. Mol. Biol. Int. 39:1996;19-21.
12. Izzotti A., Rossi G.A., Bagnasco M., De Flora S. Benzo[a]pyrene diolepoxide-DNA adducts in alveolar macrophages of smokers. Carcinogenesis (Lond.). 12:1991;1281-1285.
13. Alexandrov K., Rojas M., Geneste O., et al. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res. 52:1992;6248-6253.
14. 32P-postlabelling analysis of 7-methylguanine in human bronchial and lymphocyte DNA. Carcinogenesis (Lond.). 14:1993;151-154.
15. Petruzzelli S., Tavanti L.M., Celi A., Giuntini C. Detection of N 7-methyldeoxyguanosine adducts in human pulmonary alveolar cells. Am. J. Respir. Cell. Mol. Biol. 15:1996;216-223.
16. Piipari R., Savela K., Nurminen T., et al. Expression of CYP1A1, CYP1B1 and CYP3A and PAH-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers. Int. J. Cancer. 86:2000;610-616.
17. Hussey A.J., Hayes J.D. Human Mu-class glutathione S-transferases present in liver, skeletal muscle and testicular tissue. Biochem. Biophys. Acta. 1203:1993;131-141.
18. Saarikoski S.T., Voho A., Reinikainen M., et al. Combined effect of polymorphic GST genes on individual lung cancer risk. Int. J. Cancer. 77:1998;516-521.
19. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis (Lond.). 7:1986;1543-1551.
20. 32P-postlabeling assay. Carcinogenesis (Lond.). 12:1991;503-508.
21. Phillips DH, and Castegnaro M, on behalf of the trial participants. Standardization and validation of DNA adduct postlabeling methods: report of interlaboratory trials and production of recommended protocols. Mutagenesis 1999;14:301-315.
22. SAS Institute Inc, SAS/STAT User's Guide, Version 8, Cary, NC: SAS Institute Inc, 1999.
23. Greenland S. Introduction to regression modeling. Rothman K.J., Greenland S. Modern Epidemiology. 2nd edition: 1998;401-432 Lippincott-Raven Publishers, Philadelphia.
24. Roberts-Thomson S.J., McManus M.E., Tukey R.H., Gonzalez F.J., Holder G.M. The catalytic activity of four expressed human cytochrome P450s towards benzo(a)pyrene and the isomers of its proximate carcinogen. Biochem. Biophys. Res. Commun. 192:1993;1373-1379.
25. Hayashi S., Watanabe J., Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn. J. Cancer Res. 83:1992;866-870.
26. Stücker I., Jacquet M., de Waziers I., Cénée S., Beaune P., Kremers P., Hémon D. Relation between inducibility of CYP1A1, GSTM1 and lung cancer in a French population. Pharmacogenetics. 10:2000;617-627.
27. Shields P.G., Bowman E.D., Harrington A.M., Doan V.T., Weston A. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res. 53:1993;3486-3492.
28. Ryberg D., Skaug V., Hewer A., et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis (Lond.). 18:1997;1285-1289.